Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2018 Photo Leonie Bolleurs
Second triumph for young pollution and pharmaceutical researcher
Emmie Chiyindiko, winner of Famelab.

“I am grateful to be reaping the benefits of stepping out of my comfort zone. By facing the unfamiliar, that challenge will allow me to see what great things I am capable of,” said Emmie Chiyindiko, winner of Famelab 2018.

With FameLab, the world’s leading science communication competition, participants have just three minutes to win over the judges and crowd with a scientific talk that excels in content, clarity and charisma. Contestants from around the world participate, armed only with their wits and a few props.

Emmie won the Postgraduate School’s Three-Minute-Thesis competition for master’s level in 2017.

She said: “My research is based on the synthesis and characterisation of a series of unique metal complexes.” These complexes are used both as active pharmaceutical ingredients and cosmetic additives to reduce the detrimental effects of UV radiation on the skin. They are incorporated into anti-ulcer, gastro protective drugs, anti-asthmatic, lung disease drugs, with anti-cancer and anti-diabetic agents,” she said.

With her research she can also monitor air pollution. Formaldehyde is a known toxin to human health. “Using metal complexes, I am able to monitor the production of formaldehyde and consequently come up with exposure prevention methods,” said Emmie.

She believes that it is okay to not ”fit in“. “Mannerisms such as your quirks make you different and distinctive. Live your life intentionally, imprint your personal mark on this universe and always choose faith over fear.”

News Archive

OSM Camerata hosts concert as part of International Ictus Music Competition
2017-05-29

 

Description: OSM Camerata Ictus Music Competition Tags: OSM Camerata Ictus Music Competition
In 2015 the Odeion School of Music Camerata premiered the Hendrik Hofmeyr
Double Concerto
for Recorder and Harpsichord with esteemed South African artists
Stefan Temmingh and Erik Dippenaar.
Photo: Supplied

 

The Odeion School of Music Camerata (OSMC) at the University of the Free State (UFS) will be celebrating its fifth birthday in style when it participates in the 2017 International Ictus Music Competition. The competition is an innovative new online competition for ensembles, orchestras and band/wind ensembles (middle school, high school, youth ensemble, community ensemble and college/conservatory/university) that compete through video submission.

Opportunity for fundraising

As part of the competition the OSMC will host a concert that will also serve as a fundraising opportunity. The concert takes place on 31 May 2017 in the Odeion on the Bloemfontein Campus. The OSMC was strategically founded in 2012 by Marius Coetzee as the Odeion School of Music’s flagship chamber ensemble with the main objective of creating a catalyst for excellence.

International exposure at stake
Substantial money prizes are at stake in the International Ictus Music Competition and ensembles will receive written feedback from a jury consisting of renowned maestri including Stilian Kirov, who was awarded 1st Prize in the Debut Berlin Competition on 18 May 2017. Top prize-winners will be interviewed by a representative from the competition. It will be broadcast internationally to enable them to share their hard work and passion for music with the world.

Over the past five years the OSMC has premiered 10 new works by South African composers specially commissioned for them. A highlight remains its participation in the 13th International Conservatory Festival in St Petersburg Russia, where the ensemble received a standing ovation during a gala concert in the Glazunov Concert Hall.

Date: 31 May 2017
Time: 19:30
Place: Odeion (Bloemfontein Campus)
Entry: R20


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept